We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$355M
Cap. Flow
+$316M
Cap. Flow %
26.21%
Top 10 Hldgs %
40.06%
Holding
747
New
182
Increased
169
Reduced
181
Closed
163

Sector Composition

Rank Sector Weight
1 Healthcare 36.03%
2 Financials 28.77%
3 Technology 9.99%
4 Energy 5.75%
5 Consumer Discretionary 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHAA
651
DELISTED
Catcha Investment Corp
CHAA
-28,211
Closed -$289K
BWAQW
652
DELISTED
Blue World Acquisition Corporation Warrant
BWAQW
-76,478
Closed -$3.63K
AONCW
653
DELISTED
American Oncology Network, Inc. Warrant
AONCW
-10,387
Closed -$1.02K
OSI
654
DELISTED
Osiris Acquisition Corp.
OSI
-238,744
Closed -$2.38M
ASCAR
655
DELISTED
A SPAC I Acquisition Corp. Right
ASCAR
-50,000
Closed -$9.25K
LBBBR
656
DELISTED
Lakeshore Acquisition II Corp. Rights
LBBBR
-100,800
Closed -$21.2K
LCAHW
657
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
-50,000
Closed -$8.23K
ACAXR
658
DELISTED
Alset Capital Acquisition Corp Right
ACAXR
-450,500
Closed -$104K
ENER
659
DELISTED
Accretion Acquisition Corp
ENER
-36,090
Closed -$372K
FRXB.WS
660
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
-22,500
Closed -$4.47K
KVSA
661
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
-89,566
Closed -$908K
LIVBW
662
DELISTED
LIV Capital Acquisition Corp. II Warrants
LIVBW
-74,900
Closed -$3.83K
KNSW
663
DELISTED
KnightSwan Acquisition Corporation
KNSW
-132,239
Closed -$1.38M
SGII
664
DELISTED
Seaport Global Acquisition II Corp. Class A Common Stock
SGII
-307,270
Closed -$3.13M
CCVI
665
DELISTED
Churchill Capital Corp VI
CCVI
-307,734
Closed -$3.11M
APGB
666
DELISTED
Apollo Strategic Growth Capital II
APGB
-500,577
Closed -$5.13M
ARTE
667
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
-25,689
Closed -$266K
CANO
668
CALL
DELISTED
Cano Health, Inc.
CANO
-272
Closed -$408
CANO
669
DELISTED
Cano Health, Inc.
CANO
-400
Closed -$36.4K
SCPL
670
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
-15,000
Closed -$254K
JUN
671
DELISTED
Juniper II Corp.
JUN
-527,437
Closed -$5.47M
GFGDW
672
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
-46,828
Closed -$4.47K
RADI
673
CALL
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
-40,000
Closed -$2.5K
TYGOW
674
DELISTED
Tigo Energy, Inc. Warrant
TYGOW
-131,300
Closed -$37K
FXCOW
675
DELISTED
Financial Strategies Acquisition Corp. Warrants
FXCOW
-55,000
Closed -$1.93K

Similar funds

Cowen and Company's Q2 2023 Portfolio in Review

As of Q2 2023, Cowen and Company held 747 positions worth $1.21B, up 42% from $851M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cowen and Company deployed $316M of net new capital in Q2 2023, opening 182 new positions and adding to 169 existing holdings. Its largest new stake was NVIDIA: 1,927,500 shares worth $81.5M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Avadel Pharmaceuticals, an estimated $13.9M trimmed.

  • Cowen and Company's largest Q2 2023 buy was NVIDIA: 1,927,500 shares worth $81.5M.
  • Cowen and Company added most to Ares Acquisition Corporation in Q2 2023, an estimated $15.9M increase.
  • Cowen and Company's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $13.9M.
  • Cowen and Company fully exited Sylvamo in Q2 2023, selling an estimated $99.5M.
  • Cowen and Company's ten largest holdings make up 40% of its $1.21B portfolio in Q2 2023.
  • Cowen and Company opened 182 new positions and closed 163 in Q2 2023.
  • Cowen and Company's portfolio value rose 42% quarter-over-quarter to $1.21B.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.